Similarly, low ORP3 mRNA levels associate with worse survival of grade 3 colon cancer patients under 70 years, while low ORP3 mRNA levels seem to be beneficial for colon cancer patients with T2 tumor size. This evidence concerns the gene OSBPL3 and neoplasm.